In this HD mouse model, while MSNs are not overtly lost, DARPP-32 levels progressively decline as the disease progresses, making this reduction a hallmark of striatal degeneration in both HD patients and mice [29, 30]. This evidence concerns the gene PPP1R1B and Huntington disease.